They demonstrated that formation of liver metastasis from injected pancreatic cancer cells was not observed in TIMP1 or CD63 knockout mice, and concluded that TIMP1 from pancreatic cancer activates hepatic stellate cells (HSCs) via its receptor CD63 and mediates niche formation for metastasis. Here, CD63 is linked to pancreatic neoplasm.